Transurethral resection of the prostate (TURP) is a medical procedure that may help treat benign prostatic hyperplasia (BPH). Medicare covers TURP for people who meet their requirements. Yes, Medicare ...
Prodeon Medical, a medical device company developing minimally invasive treatments for benign prostatic hyperplasia (BPH), today announces that three scientific abstracts featuring the Urocross ® ...
Thermobalancing therapy is an advanced medical technology known for its effective and safe approach to treating men wi ...
The US Food and Drug Administration (FDA) has cleared Prodeon Medical’s implantable technology for treating lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). The ...
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential. On June 10, Profound Medical announced the successful completion of the first commercial benign ...
Among middle-aged and older men, a higher percentage of total food weight from ultraprocessed food (UPF) is associated with a higher risk for incident benign prostatic hyperplasia (BPH), according to ...